U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Tretinoin response

MedGen UID:
450498
Concept ID:
CN078026
Sign or Symptom
Synonyms: All trans retinoic acid response; ATRA response; Retin-A response
Drug:
Tretinoin
MedGen UID:
21254
Concept ID:
C0040845
Pharmacologic Substance
A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis. This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types. The oral form of tretinoin has teratogenic and embryotoxic properties. [from NCI]

Professional guidelines

PubMed

Eichenfield DZ, Sprague J, Eichenfield LF
JAMA 2021 Nov 23;326(20):2055-2067. doi: 10.1001/jama.2021.17633. PMID: 34812859
McKesey J, Tovar-Garza A, Pandya AG
Am J Clin Dermatol 2020 Apr;21(2):173-225. doi: 10.1007/s40257-019-00488-w. PMID: 31802394
Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G
Clin Interv Aging 2006;1(4):327-48. doi: 10.2147/ciia.2006.1.4.327. PMID: 18046911Free PMC Article

Curated

DailyMed Drug Label, tretinoin, 2014

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...